RPR Gencell evaluates SARP-1 gene for cardiovascular indications under agreement with LXR Jan. 11, 1999 No Comments
Pursuit of pediatric data for lisinopril will extend Zeneca's U.S. market exclusivity Jan. 11, 1999 No Comments
U.S. patent improves proprietary position of Alexion in C5 complement inhibition Dec. 30, 1998 No Comments
RSS